Trade LUNG anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pulmonx Corporation (LUNG) is trading at US$2.21, down 2.21% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$97.06M. Over the past 52 weeks, LUNG has traded between US$1.13 and US$2.89. On Syfe you can trade LUNG with $0 commission and add it to your watchlist.
| Previous close | US$2.26 |
|---|---|
| Market cap | US$97.06M |
| 52-week range | US$1.13 – US$2.89 |
| Volume | 220.38K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pulmonx Corporation
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the following geographical segments: United States, Europe, Middle East, Africa, Asia Pacific, and Other International. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Year: 2020
Pulmonx Corporation (LUNG) stock is trading at US$2.21, -2.21% from the previous close of US$2.26.
The market cap for Pulmonx Corporation (LUNG) stock is approximately US$97.06M.
The 52-week high for Pulmonx Corporation (LUNG) stock is US$2.89.
The 52-week low for Pulmonx Corporation (LUNG) stock is US$1.13.
Pulmonx Corporation (LUNG) does not currently pay a dividend.
Stay on top of LUNG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
